Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?

Critical care (London, England)

Volumn 13, Issue 2, 2009, Pages 302-

  Egi, Moritoki ^a   Bellomo, Rinaldo ^a   Reade, Michael C ^a  

^a OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTICLE; CRITICAL ILLNESS; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; HYPERGLYCEMIA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

BLOOD GLUCOSE; CRITICAL ILLNESS; GLYCEMIC INDEX; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 69849087862     PISSN: None     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc7755     Document Type: Article

References (0)